Exploring the pathogenesis and treatment of PSD from the perspective of gut microbiota

Abstract

Post-stroke depression (PSD) is a psychological disease that can occur following a stroke and is associated with serious consequences. Research on the pathogenesis and treatment of PSD is still in the infancy stage. Patients with PSD often exhibit gastrointestinal symptoms; therefore the role of gut microbiota in the pathophysiology and potential treatment effects of PSD has become a hot topic of research. In this review, describe the research on the pathogenesis and therapy of PSD. We also describe how the gut microbiota influences neurotransmitters, the endocrine system, energy metabolism, and the immune system. It was proposed that the gut microbiota is involved in the pathogenesis and treatment of PSD through the regulation of neurotransmitter levels, vagal signaling, hypothalamic–pituitary–adrenal axis activation and inhibition, hormone secretion and release, in addition to immunity and inflammation.

Keywords

• Post-Stroke Depression
• Gut Microbiota
• Neurotransmitters
• Endocrine System
• Energy Metabolism
• Immune System